Project Grant K43TW012786
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$106K
Federal Agency
Fogarty International Center
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
South Africa
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate how a Mycobacterium tuberculosis (MTB) secreted protein, Rv1075c, hijacks host histone methyltransferases to promote MTB infection. The $185,280 award, running from August 2024 to May 2025, aims to define how histone methylation changes at innate immune genes during MTB infection of...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on understanding how the bacterium Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis, regulates its rate of translational errors or "mistranslation" to survive various environmental stressors, including antibiotics. The $1,359,316 award, with a period of performance from August...
This $162,000 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to characterize the role of plasmacytoid dendritic cells (pDCs) in Mycobacterium tuberculosis (MTB) infection. The Washington University, the grant recipient, will leverage their mouse model of MTB infection to quantify pDC lung trafficking, identify the chemokine receptor required for pDC lung...
This $737,342 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports the development and validation of advanced imaging technologies to improve the detection and study of Mycobacterium tuberculosis (MTB), the causative agent of tuberculosis (TB). The key objectives are to: 1) Develop new imaging technologies capable of detecting single MTB bacteria in vitro and in vivo; 2) Use...
This $193,375 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate the role of the ESX1 secretion system in Mycobacterium tuberculosis (MTB) and its impact on treatment outcomes. The primary objectives are to use bacterial genetic approaches to assess the effects of clinically prevalent ESX1 variants on function in vitro, and to leverage mouse and...
This $246,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research supports research to investigate the role of lung repair and regeneration pathways in tuberculosis (TB). The award aims to determine the functional role of the bone morphogenetic protein (BMP) signaling pathway in TB control and reactivation, as well as characterize the cellular mechanisms of BMP pathway activation during TB...
The federal Project Grant award F31AI183831 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The $140,256 grant, awarded on September 5, 2024, supports research conducted by The Washington University in St. Louis to investigate how the Mycobacterium tuberculosis (MTB) pathogen promotes its survival within neutrophils, the most abundant immune cell type infected during tuberculosis (TB)....
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $565,149 to Health Research, Inc. Wadsworth Center Division to conduct research on RNA-based regulatory mechanisms in Mycobacterium tuberculosis (MTB). The primary objectives are to: Define the regulatory interactions of the sRNA MCR11 and its impact on gene expression in MTB. Characterize the roles of RNA-ABMR...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,350,312 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Los Angeles (UCLA) to develop a rapid phenotypic drug susceptibility testing system for tuberculosis (TB). The project aims to create and optimize novel fluorescent trehalose probes that can detect live Mycobacterium tuberculosis and assess drug resistance, addressing critical limitations...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to integrate single-cell omics and ancestry-adjusted expression quantitative trait loci (eQTL) mapping to characterize the immune response to tuberculosis (TB). The $517,185 award, with a performance period from Aug 1, 2024 to Jun 30, 2026, will fund the generation of multi-omic data from 225...